CORTEXYME, INC.
-
Open
37.06
-
Previous Close
37.12
-
Volume (Avg)
261.10k (298.26k)
-
Day's Range
36.58-40.32
-
52Wk Range
26.66-58.99
-
Market Cap.
1.10B
-
Dividend Rate ( Yield)
-
-
Beta
-
-
Shares Outstanding
29.55M
-
P/E Ratio (EPS)
-
Top Stories
-
Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation
Business Wire 3/8/2021SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, announced that it ...
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX
Yahoo -
Cortexyme Inc.
Barron's -
CRTX Apr 2021 20.000 put
Yahoo Finance -
Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation
MarketWatch 3/8/2021The MarketWatch News Department was not involved in the creation of this content. Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other ...
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX
Yahoo -
Cortexyme Inc.
Barron's -
Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation
Yahoo Finance -
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX
MarketWatch -
Cortexyme Inc.
Wall Street Journal -
Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation
Yahoo Finance -
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX
Business Insider -
Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation
Yahoo Finance -
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX
Middle East North Africa Financial Network -
Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation
wallstreet online 3/8/2021Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, announced that it has partnered with the Parkinson Study Group ...
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX
Middle East North Africa Financial Network -
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX
Benzinga.com -
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cortexyme, Inc. - CRTX
Benzinga.com
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A2EDEF1E4474B6A8D30E4E1C546FC6B21%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%27f623fe8d-c6f1-4b54-8a68-3984c1a8b219%27&-ver=%271.0%27&-impressionGuid=%27f623fe8d-c6f1-4b54-8a68-3984c1a8b219%27&-pageName=%27stocksummary%27&-uri=%27http%253A%252F%252Fwww.msn.com%252Fen-us%252Fmoney%252Fstockdetails%252Ffi-bprw8m%253FSymbol%253DCRTX%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"data"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"f623fe8dc6f14b548a683984c1a8b219"%2C"clid"%3A"2EDEF1E4474B6A8D30E4E1C546FC6B21"%2C"clidType"%3A"muid"%2C"di"%3A"7290"%2C"partner"%3A"Thomson%2BReuters"%2C"publcat"%3A"Thomson%2BReuters%252c%2BLLC"%2C"cvs"%3A"Browser"%2C"subcvs"%3A"finance"%2C"entityId"%3A"bprw8m"%2C"entitySrc"%3A"fi"%2C"provid"%3A"AAf3a78"%2C"dpt"%3A"stockdetails"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-us%27){kind=small}